no worries. Maybe an old game, but gotta' admit, there are new players.
Step back from minute to minute action and look at larger steady upward trend. I think the new leadership is being viewed as *very* positive.
Admittedly, still need to shake off the old outdated "CRIS is just a pre-clinical" biopharma. See this as a market inefficiency and buying opportunity.
Sentiment: Strong Buy